CROI 2024 Pharmacist HIV Perspectives
Integrating New Data From CROI 2024: Pharmacist Perspectives

Released: May 02, 2024

Expiration: May 01, 2025

Activity

Progress
1
Course Completed

In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, and Nimish Patel, PharmD, PhD, AAHIVP, cover the most impactful clinical studies presented at CROI 2024, including:

  • New data on long-acting ART, including:
    • The CARES study of LA CAB + RPV in a sub-Saharan African population using a public health approach
    • The IMPAACT 2017 MOCHA study evaluating switching to LA CAB + RPV in adolescents living with HIV
    • The ACTG A5359 LATITUDE study of LA CAB + RPV in people with adherence challenges to oral ART
    • Updated data from San Francisco’s Ward 86 Clinic using LA CAB + RPV in people without viral suppression at baseline
    • Case series of LA CAB (± RPV) + LEN for select people living with HIV unable to take oral ART and unable to use LA CAB + RPV alone
  • Data on HIV and STI prevention, including:
    • The impact of Doxy-PEP guideline implementation on STIs in men who have sex with men and transgender women in San Francisco
    • BIC/FTC/TAF for PEP
    • Offering PrEP following PEP